Return to homepagePandemic Pact

Long-term effects on the brain after covid-19

Grant number: 2021-06545

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $590,720

  • Funder

    Swedish Research Council

  • Principal Investigator

    Magnus Gisslen

  • Research Location

    Sweden

  • Lead Research Institution

    University of Gothenburg

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

13 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Emerging directions in tauopathy research.

Cognitive Trajectories from Preclinical Alzheimer's Disease to Dementia.

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort.

The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Regional differences in COVID-19 vaccine uptake and their determinants among Swedish older adults.

Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.

COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.